Skip to main content
. Author manuscript; available in PMC: 2022 May 24.
Published in final edited form as: JACC Cardiovasc Interv. 2021 May 24;14(10):1094–1105. doi: 10.1016/j.jcin.2021.03.049

Figure 1.

Figure 1

Competing risk cumulative incidence curves for (A) major adverse cardiac events, (B) all-cause mortality, (C) cardiac mortality, and (D) noncardiac mortality in cancer and noncancer (control) patients after percutaneous coronary intervention (PCI) and group comparison by Gray’s test.